Sign in

CIK 0001360214 · Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
450567010
Phone
615.733.4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Open-market sale Director sold 6,500 shares at $6.89 ($44,785)
  2. 8-K Event Results of operations
  3. 10-Q Report Quarterly Report
  4. 8-K Event Material agreement
  5. 8-K Event Material agreement · Regulation FD disclosure
  6. 8-K Event Material agreement
  7. 4 Open-market sale Director sold 6,500 shares at $7.91 ($51,415)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Shareholder vote results
  13. 4 Open-market sale Director sold 10,000 shares at $5.78 ($57,800)
  14. 8-K Event Other events
  15. 8-K Event Material agreement · New debt or obligation
  16. 8-K Event Regulation FD disclosure
  17. 8-K Event Other events
  18. 8-K Event Results of operations
  19. 10-Q Report Quarterly Report
  20. 4 Open-market sale Director sold 10,000 shares at $4.57 ($45,700)

Page 20 of 44 · 872 filings